Thaum lub Cuaj Hlis 28, 2021, Lub Tsev Haujlwm Saib Xyuas Kev Noj Qab Haus Huv (DHCS) yuav muaj lub rooj sib hais rau pej xeem hauv webinar los sib tham txog cov kev hloov pauv rau kev tso npe kawm thiab cov txheej txheem rau Medi-Cal rau npe rau cov kws muag tshuaj thiab cov khw muag tshuaj nrhiav kom muab kev pabcuam Diabetes Prevention Program (DPP). Koj raug caw tuaj koom DHCS cov neeg ua haujlwm los tham txog cov kev hloov pauv no.​​ 

Thov nrhiav cov ntaub ntawv ntawm lub rooj sib tham thiab Webex hauv qab no:
Hnub Tuesday, Cuaj Hlis 28, 2021
10:30 sawv ntxov - 12 tav su
Webex
Tus lej tshwm sim: 145 083 2864
Tus lej zais: tus neeg koom nrog​​ 

Thov sau npe ua ntej rau lub rooj sib tham Webex​​ .​​  The registration password is PED1. Call-in participants who do not register for the webinar will not be able to make oral public comments during the meeting.​​ 

DHCS proposes that these enrolled pharmacists and pharmacies be able to apply for approval to receive reimbursement for providing DPP services by submitting a Supplemental Changes e-Form in PAVE instead of submitting a full application. Please see the draft provider bulletin for more information.​​  

Written comments, questions, or suggestions can be submitted during the hearing. Based on the public comments received, DHCS will publish the final bulletin on the Medi-Cal and DHCS websites. The changes will become effective 30 days after publication.​​ 

If you are unable to attend the hearing, written comments received by 5 p.m. on September 28 will be considered prior to publication. When submitting your comments in writing, please ensure the commenter and organization/association being represented are both identified in the comments. You may submit written comments to DHCSPEDStakeholder@dhcs.ca.gov.​​